Aptevo Therapeutics Inc Share Price
NASDAQ: APVOHealthcare
Live Aptevo Therapeutics Inc Share Price Chart
O H L
Aptevo Therapeutics Inc Performance Overview
Days Range
▼
$1.77Low
$1.89High
Markets Today
| Previous Close | $1.84 |
|---|---|
| Open | $1.89 |
| Volume | 425,020 |
| Day's Range | $1.77 - $1.89 |
| 52W Range | $1.37 - $45.90 |
| Market Cap | $3.11 M |
Historical Performance
| 1M Returns | -36.55 |
|---|---|
| 3M Returns | -60.60 |
| 6M Returns | -60.60 |
| 1Y Returns | -94.84 |
| 5Y Returns | -100.00 |
| 10Y Returns | -100.00 |
Aptevo Therapeutics Inc Fundamentals
| Market Cap | $3.11 M |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $0.00 |
| ROE TTM | -2.49 |
| EPS TTM | $-58.09 |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 0.40 |
| EBITDA | $-26.07 M |
| Profit Margin | N/A |
| Market Cap | $3.11 M |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $0.00 |
| ROE TTM | -2.49 |
| EPS TTM | $-58.09 |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 0.40 |
| EBITDA | $-26.07 M |
| Profit Margin | N/A |
Aptevo Therapeutics Inc Profit & Loss
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Total Revenue + | $0 | $0 | $0 | $0 | $0 | $0 |
| Gross Profit + | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating Income | -$6.48 M | -$6.23 M | -$7.61 M | -$6.00 M | -$6.84 M | -$6.44 M |
| EBITDA | -$6.42 M | -$6.18 M | -$7.56 M | -$5.92 M | -$6.80 M | -$6.41 M |
| Interest Expense | $0 | $0 | $0 | $0 | $0 | $0 |
| Depreciation | $61.00 K | $49.00 K | $49.00 K | $81.00 K | $35.00 K | $32.00 K |
| Income Before Tax | -$6.41 M | -$6.20 M | -$7.55 M | -$5.81 M | -$6.70 M | -$6.36 M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income + | -$6.41 M | -$6.20 M | -$7.55 M | -$5.81 M | -$6.70 M | -$6.36 M |
| Net Profit Margin | - | - | - | - | - | - |
Aptevo Therapeutics Inc Financials Balance Sheet In USD
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Share Capital | $84.00 K | $99.00 K | $110.00 K | $114.00 K | $114.00 K | $114.00 K |
| Reserve & Surplus | -$253.99 M | -$260.19 M | -$269.22 M | -$275.12 M | -$281.91 M | -$288.26 M |
| Non-Current Liabilities | $4.42 M | $4.21 M | $3.99 M | $3.76 M | $3.53 M | $3.29 M |
| Current Liabilities | $5.39 M | $4.89 M | $5.61 M | $6.05 M | $4.76 M | $5.19 M |
| Total Liabilities | $9.81 M | $9.10 M | $9.60 M | $9.81 M | $8.29 M | $8.48 M |
| Fixed Assets | $482.00 K | $432.00 K | $384.00 K | $303.00 K | $268.00 K | $236.00 K |
| Current Assets | $3.61 M | $11.08 M | $22.65 M | $23.08 M | $15.98 M | $10.80 M |
| Total Assets | $8.34 M | $15.62 M | $27.00 M | $27.19 M | $19.90 M | $14.52 M |
Aptevo Therapeutics Inc Cash Flow
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Net Income | -$6.41 M | -$6.20 M | -$7.55 M | -$5.81 M | -$6.70 M | -$6.36 M |
| Operating Cash Flow | -$6.58 M | -$7.09 M | -$6.69 M | -$5.24 M | -$7.96 M | -$5.45 M |
| Investing Cash Flow | $0 | $0 | $0 | $0 | $0 | $0 |
| Financing Cash Flow | $0 | $14.36 M | $18.34 M | $5.79 M | $871.00 K | $726.00 K |
| Change in Cash | -$6.58 M | $7.27 M | $11.65 M | $558.00 K | -$7.09 M | -$4.73 M |
Aptevo Therapeutics Inc Return Calculator
The Aptevo Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$0
Invested Amount$10,000
Est. Returns$-10,000
About Aptevo Therapeutics Inc
Aptevo Therapeutics Inc is a clinical-stage research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidates are; ALG.APV-527, which targets co-stimulatory receptors and tumor antigens, and CD3xCD123, which is being developed as a potential treatment of frontline acute myelogenous leukemia. The company's preclinical candidates, APVO711, CD3xCD123, APVO0442, and APVO603, are being developed using the ADAPTIR modular protein technology platform. The company's versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells.
Popular Stocks
FAQs
What is the share price of Aptevo Therapeutics Inc today?
Aptevo Therapeutics Inc (APVO) share price as of September 18, 2026 is $1.78. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of Aptevo Therapeutics Inc?
Yes, Indian Investors can invest in the Aptevo Therapeutics Inc (APVO) Share by opening an international trading account with Angel One.
How can I purchase Aptevo Therapeutics Inc shares in India?
Purchasing Aptevo Therapeutics Inc (APVO) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Aptevo Therapeutics Inc (APVO) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of Aptevo Therapeutics Inc?
Yes, you can purchase fractional shares of Aptevo Therapeutics Inc (APVO) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of Aptevo Therapeutics Inc?
The market capitalization of Aptevo Therapeutics Inc on September 18, 2026, is $3.11 M.
In which sector Aptevo Therapeutics Inc belongs?
Aptevo Therapeutics Inc operates in the Healthcare sector, specifically in the Healthcare industry.
What documents are required to invest in Aptevo Therapeutics Inc stocks?
In order to invest in Aptevo Therapeutics Inc (APVO) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
